108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE
Appoints Kristin Stafford as Chief Financial Officer
Enter into $250 Million Royalty-Backed Note Financing
Earnings Release
Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Zymeworks Inc. Annual Meeting Vote Results Announced
Appoints Scott Platshon as Acting Chief Investment Officer
Zymeworks' Positive Phase 3 Results for Ziihera® in HER2-Positive Gastroesophageal Cancer
Annual Report to Security Holders
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership